The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Clindamycin 300 mg Capsules



EG (Eurogenerics)PA25213/001/001

Main Information

Trade NameClindamycin 300 mg Capsules
Active SubstancesClindamycin hydrochloride
Dosage FormCapsule, hard
Licence HolderEG (Eurogenerics)
Licence NumberPA25213/001/001

Group Information

ATC CodeD10AF Antiinfectives for treatment of acne
D10AF01 clindamycin
G01AA Antibiotics
G01AA10 clindamycin
J01F MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS

Status

License statusAuthorised
Licence Issued15/05/2009
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version
« Back